Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20161116002Phase 1Completed
Phase 1, open-label, single-arm trial of clopidogrel in cardiac morbidity, sponsored by none. Primary endpoints: Pharmacokinetic parameters of clopidogrel and Pharmacodynamic response to clopidogrel. Started Mar 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20161116002.